About Us  |  BVA-100  |  Investor Relations  |  IDANT Division  |  Contact Us

About Us: Management


11/17/2014 - Daxor Corporation Announces Payment of a Dividend


11/3/2014 - Daxor Announces Publication of a Study Comparing Two Widely Used Surrogate Tests for Estimating Blood Volume with Direct Measurement of Blood Volume


10/21/2014 - Daxor Corporation Announces Research Agreement with Virginia Commonwealth University on Burn Patients



  Form N-Q for Sep 30, 2014  
  Form N-CSR for Jun 30, 2014  
  Form NSAR-B for Dec 31, 2013  
  Form N-Q for Mar 31, 2014  


Executive Team

Joseph Feldschuh, M.D.

President and CEO

David Frankel

Chief Financial Officer

Diane Meegan

Corporate Secretary

Gary Fischman, Ph.D.

Vice President, Research and Development
Board of Directors  

Joseph Feldschuh, M.D.

Chairman of the Board

Michael R. Feldschuh

Director of the Company

James A. Lombard

Director of the Company

Martin S. Wolpoff

Director of the Company

Robert Willens

Director of the Company

Bernhard Saxe

Director of the Company
Medical Advisory Board  

Philip Frost, M.D.


Robert L. Rosenthal, M.D.


Fred Gilbert, M.D.


James H. Brassel, M.D.

Menu Options

DAXOR Home Page

Mission Statement

Privacy Statement

Company Management


Contact Us




350 Fifth Ave.
Suite 7120
New York, NY 10118
Phone: 212-330-8500
Fax: 212-244-0806

© 2014 DAXOR Corporation. All Rights Reserved.